BRAF and melanoma: Results from clinical trials have revealed that the therapeutic efficacy of these approaches are comparable,21,440–442 and indirect side-by-side analysis also supports this conclusion.443 The development of these combinations provides more options for patients with advanced melanoma harboring BRAF mutation.